NUTRITION IN CONTEXTNovember 16, 2026
Heart Nutrition
Brief
Heart Health / EVIDENCE GUIDE

Vitamin D Supplements and Cardiovascular Events: Why Two Large Trials Need Careful Reading

Compare VITAL and D-Health findings on vitamin D supplements and cardiovascular events without turning mixed trial results into prevention claims.

Vitamin D fortification in table spreads
Vitamin D and Margarine · DanDan555 · CC BY-SA 4.0 · Source · License
THE KEY TAKEAWAY

Large vitamin D trials do not support a broad claim that routine supplementation prevents cardiovascular disease, though D-Health produced a small, uncertain signal that warrants study.

A nutrient need and a prevention claim are different

Vitamin D is essential for bone and mineral health, and deficiency can require clinical attention. That established nutritional role does not automatically prove that taking extra vitamin D prevents heart attacks or strokes. Prevention claims must be tested in randomized trials that measure cardiovascular events, not inferred from laboratory mechanisms, observational associations, or a product’s ability to raise a blood level.

This distinction also prevents an unhelpful all-or-nothing conclusion. A neutral cardiovascular trial does not mean vitamin D has no biological role, and it does not negate treatment of a documented deficiency. It means the tested supplementation strategy did not clearly deliver the broad cardiovascular benefit that many consumers assume from the phrase heart health.

This photo shows a beautifully plated seafood dish. The main feature appears to be a piece of salmon topped with a large, pink shrimp that's garnished with fresh dill. On the side, there's a small portion of coleslaw and
DFC 1021 Seared salmon fillet topped with shrimp and dill served with coleslaw roasted potatoes and a side of creamed spinach on a bed of greens · PattayaPatrol · CC BY-SA 4.0 · Source · License

What VITAL tested

VITAL randomly assigned 25,871 U.S. adults to vitamin D3 at 2,000 IU daily or placebo, within a factorial trial that also tested marine omega-3s. Participants were generally not selected for vitamin D deficiency. Over a median 5.3 years, vitamin D did not significantly reduce the primary composite of myocardial infarction, stroke, or cardiovascular death.

The population and intervention define the result. VITAL does not answer every question about treating severe deficiency, every dose, or every younger population. It does directly challenge the idea that routine high-dose supplementation broadly prevents major cardiovascular events among generally healthy middle-aged and older adults. Subgroup observations should be treated as exploratory unless replicated in trials designed for those groups.

How D-Health adds uncertainty rather than certainty

The Australian D-Health trial assigned 21,315 adults ages 60 to 84 to 60,000 IU of vitamin D3 monthly or placebo. Its cardiovascular analysis reported a hazard ratio of 0.91 for major cardiovascular events, with a 95% confidence interval from 0.81 to 1.01. Because that interval included no effect, the primary result was not conventionally statistically significant.

Researchers described a possible benefit and a small absolute difference, while emphasizing uncertainty. Individual outcomes and medication subgroups generated signals, but interaction testing did not establish that the effect truly differed by baseline cardiovascular drug use. Reading only the most favorable number would overstate the trial. Together, VITAL and D-Health justify further research, not a general prevention promise.

Dose pattern and baseline status matter

Daily and monthly dosing are not identical exposures. Baseline vitamin D status, sun exposure, diet, body size, age, and health conditions also influence blood levels. A product advertisement that combines the two trials without describing these differences can create a false impression of a single, settled answer. Trial participants also faced specific eligibility criteria that may not match an individual shopper.

More is not necessarily better. NIH’s Office of Dietary Supplements lists a tolerable upper intake level of 4,000 IU daily for most adults, while clinicians may temporarily use other regimens for specific conditions. Excess vitamin D can cause hypercalcemia and related complications. Multiple products—multivitamins, calcium blends, and standalone capsules—can quietly add to the total.

Aoraki Mt Cook Salmon
Aoraki Mt Cook Salmon (28952782350) · US Embassy from New Zealand · CC BY 2.0 · Source · License

A better reason to test or supplement

Decisions should begin with the actual clinical question: dietary adequacy, risk factors for deficiency, a measured level when testing is appropriate, bone health, or treatment of a diagnosed problem. A cardiovascular prevention goal deserves therapies and lifestyle measures supported for that purpose. Vitamin D should not displace blood-pressure control, lipid treatment, smoking cessation, physical activity, or an evidence-based eating pattern.

Bring every supplement label to a clinician or pharmacist, especially with kidney disease, high calcium, kidney stones, sarcoidosis, or interacting medicines. The evidence does not support presenting vitamin D as a guaranteed heart-protection capsule. Its appropriate use is more precise: meet nutritional needs and treat relevant deficiencies while keeping cardiovascular claims attached to the endpoints that trials actually measured.

How to read the next vitamin D headline

Check whether a report describes a prespecified primary outcome or a secondary analysis, and look for the absolute event difference alongside the relative estimate. A confidence interval that crosses no effect signals uncertainty even when the point estimate looks favorable.

Also ask whether participants were deficient at baseline and whether the study tested daily, monthly, or intermittent dosing. Those details determine what the result can reasonably say. A new subgroup finding should generate a focused trial before it becomes a recommendation for millions of supplement users.

Sources & further reading

  1. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL) ↗
  2. Vitamin D Supplementation and Major Cardiovascular Events: D-Health Trial ↗
  3. NIH ODS: Vitamin D—Health Professional Fact Sheet ↗

This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.

More on Heart Health →